CD4+ T-lymphocyte recognizing tetanus toxin epitopes P30 and P2 (TT-specific CD4+ T cell) (TT-specific CD4+ T cell)

CD4+ T-lymphocytes recognizing the P30 and P2 epitopes of tetanus toxin represent a specific subset of memory helper T cells prevalent in the human population due to widespread tetanus vaccination. These epitopes, P2 (residues 830–844) and P30 (residues 947–967), are characterized as universal or promiscuous because they can be presented by a wide array of HLA-DR molecules, ensuring recognition by T cells in most individuals (Panina-Bordignon et al., 1989; PubMed: 2515065). In a therapeutic context, these cells are leveraged to provide potent bystander help; by incorporating P2 and P30 sequences into vaccines or chimeric antigen receptor (CAR) constructs, researchers can trigger these pre-existing memory T cells to secrete cytokines like IL-2 and IFN-gamma (Valmori et al., 1992; PubMed: 1374450). This activation enhances the recruitment and maturation of other immune cells, such as B cells or cytotoxic T cells, directed against a primary target like a pathogen or tumor. Consequently, these T cells serve as a biological platform for boosting vaccine efficacy and overcoming immunosuppressive environments in oncology (Demotz et al., 1989; PubMed: 2470817). Their interaction with drugs primarily occurs through the administration of tetanus toxoid or synthetic peptides, which act as agonists to stimulate the T-cell receptor (TCR) complex on these specific lymphocytes.

Other names

Tetanus toxin-specific CD4+ T cellP2/P30-reactive T cellUniversal T-cell epitope-specific lymphocyteTetanus toxoid-specific helper T cell

Activation of pre-existing memory CD4+ T cells through MHC class II-mediated presentation of universal tetanus epitopes, leading to cytokine secretion and enhanced immune recruitment.